Unraveling Endocannabinoid Signaling Pathways in Cisplatin‐Induced Ototoxicity
The FASEB Journal · 2026
DOI: 10.1096/fj.202502888rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Sakthimala Palaniappan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy. Hauptthemen laut MEDLINE: Cisplatin, Endocannabinoids, Signal Transduction, Hair Cells, Auditory. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Research (MUR), Dompé Farmaceutici S.p.A, Ministero dell'Università e della Ricerca.
Abstract (Originalsprache)
Cisplatin‐induced ototoxicity is a detrimental side effect of chemotherapy leading to hearing loss, for which no treatments are currently available. Despite the growing recognition of the endocannabinoid (eCB) system (ECS) as a significant contributor to different physiological and pathological processes, its role in hearing remains poorly investigated. To fill this knowledge gap, we performed a molecular profiling of the ECS in auditory hair cell (HC)‐like UB/OC1 cells derived from the mouse organ of Corti (OC), demonstrating the presence of the main eCBs‐binding receptors and metabolic enzymes along with the major eCBs ( N ‐arachidonoylethanolamine, AEA, and 2‐arachidonoylglycerol, 2‐AG) and additional eCB‐like compounds. Subsequently, we established an in vitro model of cisplatin‐induced ototoxicity, which was characterized by the downregulation of the HC marker myosin 7a (Myo 7a), and activation of nuclear factor kappa‐light‐chain‐enhancer of activated B‐cells (NF‐κB) associated with caspase‐3‐mediated cell death. In this model, we observed a downregulation of cannabinoid receptor 2 (CB 2 R), diacylglycerol lipase β (DAGLβ), and α/β hydrolase domain‐containing protein 6 (ABHD6), indicating a perturbation of the 2‐AG metabolic pathway. Furthermore, we validated the observed in vitro alterations in the OC of an in vivo model of cisplatin‐induced ototoxicity, thereby strengthening the physiological relevance of our findings. Finally, we demonstrated that pharmacological blockade of CB 2 R through SR144528 mitigates cisplatin‐induced HC damage via inhibition of caspase‐3 cleavage in UB/OC1 HC‐like cells, thereby providing novel mechanistic insights into the role of CB 2 R in ototoxicity. Overall, our study demonstrates the involvement of selective elements of the ECS in cisplatin‐induced ototoxicity, hence identifying novel potential biomolecular targets for chemotherapy‐related side effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
- European Center for Brain Research (CERC), Santa Lucia Foundation IRCCS, Rome, Italy.
- Department of Otorhinolaryngology and Head & Neck Surgery, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
- UMC Utrecht Brain Center, Utrecht University, Utrecht, the Netherlands.
- Department of Bioscience and Technology for Food, Agriculture and Environment, University of Teramo, Teramo, Italy.
- Leibniz Research Institute for Molecular Pharmacology (FMP), Campus Berlin-Buch, Berlin, Germany.
ORCID-Profile: Annamaria Tisi, Mauro Maccarrone
Förderung
- Italian Ministry of Research (MUR)
- Dompé Farmaceutici S.p.A
- Ministero dell'Università e della Ricerca
Zitieren
APA
Palaniappan, S., Tisi, A., Di Meo, C., Urbano, C., Fenton, G. E., Della Valle, F., Fanti, F., Compagnone, D., Nazarè, M., Versnel, H., Aramini, A., Allegretti, M., & Maccarrone, M. (2026). Unraveling Endocannabinoid Signaling Pathways in Cisplatin‐Induced Ototoxicity. The FASEB Journal. https://doi.org/10.1096/fj.202502888rr
Vancouver
Palaniappan S, Tisi A, Di Meo C, Urbano C, Fenton GE, Della Valle F, et al. Unraveling Endocannabinoid Signaling Pathways in Cisplatin‐Induced Ototoxicity. The FASEB Journal. 2026. doi:10.1096/fj.202502888rr
BibTeX
@article{Palaniappan2026,
author = {Palaniappan, Sakthimala and Tisi, Annamaria and Di Meo, Camilla and Urbano, Cristina and Fenton, Georgina E and Della Valle, Francesco and Fanti, Federico and Compagnone, Dario and Nazarè, Marc and Versnel, Huib and Aramini, Andrea and Allegretti, Marcello and Maccarrone, Mauro},
title = {Unraveling Endocannabinoid Signaling Pathways in Cisplatin‐Induced Ototoxicity},
journal = {The FASEB Journal},
year = {2026},
doi = {10.1096/fj.202502888rr}
}
EUVIMED